Towards Personalized Dosing of Natalizumab in Multiple Sclerosis
Clinical trial NCT03516526 · COMPLETED
Trial details
- NCT number
- NCT03516526
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-03
- Primary completion
- 2019-06-21
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.